和铂医药-B 港股通 空最新回购 (2026-01-02) 官网 ( 02142.hk) | 19.12 | 4.94 | 0% | 上市时间2020-12-10股价12.24港币涨跌幅3.55%成交金额3,173.16万港币换手率0.29%市值109.61亿港币H股市值109.61亿港币总股本8.96亿H股本8.96亿每手股数1,000上市至今年化投资收益率2.08%港股通持仓占H股比例2.35% (2.46亿港币2026-02-13) 累计做空占H股比例4.86% (4.80亿港币2026-02-06) | |||
| 所属三级行业生物技术 (恒生) | 市盈率 | 69.49 | 市净率 | 5.27 | 股息率 | 0.30% | 恒生:医疗保健业药品及生物科技生物技术 |
| 备注 (5): | 双击编辑备注 |
和铂医药-B(02142) - 历史董事名单
| # | 姓名 | 职衔 | 职位 | 委任日期 | 辞任日期 |
|---|---|---|---|---|---|
| 1 | COLLINSON Albert R. | Independent Non Executive Director | 2023-07-13 | -- | |
| 2 | 戎一平 | Executive Director | 2022-05-05 | -- | |
| 3 | 陳小祥 | Executive Director | 2021-09-17 | 2022-05-05 | |
| 4 | 陳維維 | Non Executive Director | 2021-06-09 | -- | |
| 5 | 邱家賜 | Independent Non Executive Director | 2021-06-09 | -- | |
| 6 | 葉小平 | Independent Non Executive Director | 2020-11-30 | -- | |
| 7 | 陳維維 | Independent Non Executive Director - A/F | 2020-11-30 | 2021-06-09 | |
| 8 | DESHPANDE Atul Mukund | Executive Director | 2020-08-10 | 2021-04-25 | |
| 9 | 王俊峰 | Non Executive Director | 2018-03-21 | 2023-07-13 | |
| 10 | 廖邁菁 | Executive Director | 2018-01-18 | 2021-09-17 | |
| 11 | KAMEN Robert Irwin | Independent Non Executive Director | 2016-12-07 | -- | |
| 12 | 裘育敏 | Non Executive Director | 2016-12-07 | 2023-07-13 | |
| 13 | 王勁松 | Executive Director | Chairman, CEO | 2016-07-20 | -- |